Japan Asset Strategy Leader
AbbVie
Japan Asset Strategy Leader
AbbVie
Global biopharmaceutical company developing medicines
Purpose Statement:
Japan Asset Strategy Leader (JASL) serves as the matrix team leader to bring impactful medicine to patients as quickly and efficiently as possible, working as one with global team and internal/external stakeholders by driving plan & implementation of the most competitive Japan asset strategies for asset value maximization
Responsibilities:
Roles:
Develop and drive an integrated Japan asset strategy for value maximization
Lead JAST
Background/Experience
Education
Knowledge
Skill
アッヴィは、機会均等を重視する雇用主であり、誠実な企業活動、革新の推進、人々の生活への貢献、そして地域社会への貢献に努めています。雇用機会均等に向けて、障がいを持つ方々も積極的に支援しています。
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Explore more opportunities at AbbVie